Vaccine Therapy in Treating Patients With Metastatic Melanoma

Clinical trial NCT00022568 · UNKNOWN

Trial details

NCT number: NCT00022568
Sponsor: Herbert Irving Comprehensive Cancer Center
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2001-08-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.